The Most Bioavailable Coenzyme Q10
Oral Supplement Available Today
Oral Supplement Available Today
About Tishcon Corp.:
Licensed Patents
1. Biosolv - Biosytes (Goldman) - Q-Gel®
U.S. Patent No. 6,056,971 (Expires July 23, 2017)
2. Enhanced Bioavailablility of CoQ10
U.S. Patent No. 6,300,377 (Raj Chopra) - "Hyrdosolv" (Expires February 22, 2021)
3. Composition of palatable Oral CoQ10 Liquid
U.S. Patent No. 6,441,050 (Raj Chopra) - "Opti-solv" (Expires August 29, 2029)
4. Q-Nol® (Reduced CoQ10)
U.S. Patent No. 6,740,338 (Raj Chopra) - "Q-Nol" (Expires May, 2024)
5. Reduced Form of Coenzyme Q10 in High Bioavailability - stable dosage forms and related applications
Canadian Patent No. 2,397,447 (Raj Chopra) - "Q-Nol" (Expires January 18, 2021)
6. Palatable Oral Coenzyme Q10 Liquid
Canadian Patent No. 2,417,289 (Raj Chopra) - "Q-Nol" (Expires August 17, 2021)
7. HydroQsorb
U.S. Patent No. 6,861,447 (Wacker)
8. LiQsorb
U.S. Patent No. 6,455,072 (3i)
9. Bioslov - Biosytes (Goldman) - Q-Gel®
Canadian Patent No. 2,236,023
Looking to enhance your existing product line or create a new one?
The applications for the Q-Gel® product line have an extended reach. Tishcon Corp., one of the leaders in Coenzyme Q10 (CoQ10) research, education and contract manufacturing can provide all our products in bulkpacks or labeled in consumer packages to your specifications.Contact Tishcon
CoQ10 Product Sheets:
Click any image below to downloada PDF version of our product sheets:
 Overview |
 Li Q H |
 Li Q Sorb |
 Hydro Q Sorb |
